Drug Shortage Report for IDARUBICIN
Report ID | 219730 |
Drug Identification Number | 02410028 |
Brand name | IDARUBICIN |
Common or Proper name | IDARUBICIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | IDARUBICIN HYDROCHLORIDE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1X20 ML |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-15 |
Actual start date | |
Estimated end date | 2024-09-02 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | Other presentation available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-16 | English | Compare |
v2 | 2024-02-15 | French | Compare |
v1 | 2024-02-15 | English | Compare |
Showing 1 to 3 of 3